Article

abqjournal.comabqjournal.com on 2021-07-10 18:36

Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

WHIPPANY, N.J.--(BUSINESS WIRE)--Jul 10, 2021-- Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved ...

Related news